Society for Translational Oncology Fellows’ Forum (STOFF)

The Lansdowne, Leesburg, VA, USA
January 27 – January 29, 2022


PORTAL OPEN NOW - CLOSES: October 15, 2021

Society for Translational Oncology Fellows' Forum (STOFF) is an intensive 3-day workshop that brings together fellows and junior faculty within 5 years of training completion from the leading medical, surgical, radiation, and pediatric oncology groups and subspecialty fellowships to educate these rising stars on issues around and barriers to successful translational cancer research. A distinguished faculty of prominent scientists, clinicians, ethicists, industry representatives, and biotech investors serve as mentors.

The cornerstones of STOFF are the faculty members who volunteer both their time and wealth of experience. Co-chaired by Keith Flaherty (Massachusetts General Hospital/Harvard Medical School), Stacey Berg (Baylor College of Medicine), and Ross Levine (Memorial Sloan Kettering Cancer Center), the STOFF faculty includes researchers and educators from the US FDA and several leading US cancer centers.

The workshop has received international acclaim for its focused, practical, and personal approach, including opportunities for networking with peers and mentoring from faculty. The broad-based curriculum covers a range of topics related to new drug development. Faculty lecture and lead discussions on preclinical and clinical evaluation, validation of targets and biomarkers, confirmation of mechanism of action and resistance in clinical trials, and racial and age-related disparities in clinical trials, and includes the mechanics of grant-writing and guidelines for good basic research.

Educating young oncologists in the field of clinical and translational research is an investment in the future and is likely to impact the quality of cancer patient care for years to come,” said Bruce A. Chabner (Massachusetts General Hospital/Harvard Medical School), who founded the course more than two decades ago. Since then, many of the 540+ alumni have earned significant acclaim in their careers and drug development success.

* The number of scholars selected for participation will be limited to 25 in order to provide ample opportunity
for one-on-one interface with the faculty as well as peer-to-peer networking.

STOFF will be held January 27 – January 29, 2022, at The Lansdowne in Leesburg, VA.

Preliminary agenda:
Thursday, January 27, 2022 – Welcome reception/dinner and keynote speaker, beginning at 6pm
Friday, January 28, 2022 – Full day workshop followed by group activity/networking
Saturday, January 29, 2022 – Half day workshop and closing lunch


Applicants must currently be enrolled in an accredited hematology/oncology or subspecialty training program or be junior faculty within 5 years of training completion with a demonstrated commitment to translational cancer research.  STO is committed to the training and mentoring of talented fellows and junior faculty, and we encourage applicants from diverse backgrounds and those underrepresented in the field of translational oncology.

To apply, candidates should electronically forward the following:

  1. current CV
  2. letter of recommendation from department chairman or program director; and
  3. one-page letter describing applicant’s purpose in attending the program, including a brief description of past/ongoing activities illustrating interest in the field.

Upon acceptance scholars will be required to agree to participate in the following:

  • Write a summary of an assigned STOFF presentation in abstract form of approximately 500 words within two weeks of STOFF completion.
  • Respond to 5-minute surveys from STO after three and six months regarding daily practice and career/research path.

All three application components must be transmitted at the same time to No partial submissions will be considered.

Application Portal closes: OCTOBER 15, 2021.
Notifications will be made by: NOVEMBER 15, 2021.

Tuition expenses, course materials, travel, housing, and meals
will be covered for successful applicants.